Open Orphan plc changes its name to hVIVO plc, learn more here.

13 Feb 2024
Go Back

Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults

Share this:

Co-authored by Alexander Mann – Senior Director of Clinical Science, Andrew Catchpole – Chief Scientific Officer, Mariya Kalinova – Medical Director

Other recent posts

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO
chevron-down